PCN50 COSTS OF TREATMENT WITH ANGIOGENESIS INHIBITORS (AIS) IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA (MRCC)- RESULTS FROM A MEDICAL CHART REVIEW STUDY
May 1, 2010, 00:00 AM
10.1016/S1098-3015(10)72139-2
https://www.valueinhealthjournal.com/article/S1098-3015(10)72139-2/fulltext
Section Title :
Section Order :
718
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)72139-2&doi=10.1016/S1098-3015(10)72139-2